JP2019524871A5 - - Google Patents

Download PDF

Info

Publication number
JP2019524871A5
JP2019524871A5 JP2019517203A JP2019517203A JP2019524871A5 JP 2019524871 A5 JP2019524871 A5 JP 2019524871A5 JP 2019517203 A JP2019517203 A JP 2019517203A JP 2019517203 A JP2019517203 A JP 2019517203A JP 2019524871 A5 JP2019524871 A5 JP 2019524871A5
Authority
JP
Japan
Prior art keywords
conjugate
pharmaceutical composition
group
peg
attached
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019517203A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019524871A (ja
JP7081832B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/037303 external-priority patent/WO2017218569A2/en
Publication of JP2019524871A publication Critical patent/JP2019524871A/ja
Publication of JP2019524871A5 publication Critical patent/JP2019524871A5/ja
Application granted granted Critical
Publication of JP7081832B2 publication Critical patent/JP7081832B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019517203A 2016-06-13 2017-06-13 α（Ｖ）β（６）インテグリン結合ペプチドおよびその使用方法 Active JP7081832B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662349615P 2016-06-13 2016-06-13
US62/349,615 2016-06-13
PCT/US2017/037303 WO2017218569A2 (en) 2016-06-13 2017-06-13 Alpha(v)beta(6) integrin-binding peptides and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2019524871A JP2019524871A (ja) 2019-09-05
JP2019524871A5 true JP2019524871A5 (enExample) 2021-04-22
JP7081832B2 JP7081832B2 (ja) 2022-06-07

Family

ID=60664208

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019517203A Active JP7081832B2 (ja) 2016-06-13 2017-06-13 α（Ｖ）β（６）インテグリン結合ペプチドおよびその使用方法

Country Status (7)

Country Link
US (2) US11185601B2 (enExample)
EP (1) EP3468984A4 (enExample)
JP (1) JP7081832B2 (enExample)
CN (1) CN109563135B (enExample)
AU (1) AU2017283537B2 (enExample)
CA (1) CA3027364A1 (enExample)
WO (1) WO2017218569A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3131566B1 (en) * 2014-04-15 2022-10-05 The Regents of the University of California Bi-terminal pegylated integrin-binding peptides and methods of use thereof
JP7081832B2 (ja) 2016-06-13 2022-06-07 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア α（Ｖ）β（６）インテグリン結合ペプチドおよびその使用方法
EP3846858A4 (en) 2018-09-07 2022-10-19 The Regents of the University of California Alpha(v)beta(6) integrin-binding peptides and methods of use thereof
AU2020370362A1 (en) * 2019-10-25 2022-06-02 Children's Medical Center Corporation Computational design of alpha(v) beta (6) integrin binding proteins
JP2023512634A (ja) * 2020-01-21 2023-03-28 クアンタム－エスアイ インコーポレイテッド Ｃ末端の選択的標識のための化合物および方法
JP7787083B2 (ja) * 2020-03-12 2025-12-16 テフニーシェ ウニヴェルジテート ミュンヘン アルファ－ｖ－ベータ－６－インテグリンをインビボでアドレッシングするための環状ペプチド及びそれらのコンジュゲート
JP2023552383A (ja) * 2020-12-04 2023-12-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ペプチド受容体放射性核種療法
EP4637731A1 (en) 2022-12-21 2025-10-29 Gilead Sciences, Inc. Combination therapy for treating cancer
WO2024263637A1 (en) 2023-06-20 2024-12-26 The Regents Of The University Of California Combination therapy with peptide receptor radionuclide and dna repair inhibitor
WO2026067489A1 (zh) * 2024-09-29 2026-04-02 四川科伦博泰生物医药股份有限公司 ITGβ6结合蛋白及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429133A (en) * 1992-12-18 1995-07-04 Neoprobe Corporation Radiation responsive laparoscopic instrument
DE10154180A1 (de) * 2001-11-05 2003-05-15 Basf Ag gene die für genetische Stabilitäts-, genexpressions-und Faltungsproteine codieren
EP1686114B1 (en) 2003-11-18 2009-10-07 Mitsubishi Gas Chemical Company, Inc. Process for producing optically active 2-alkylcysteine, derivative thereof, and processes for production
GB0520068D0 (en) * 2005-10-03 2005-11-09 Cancer Res Technology av peptide ligand
GB0718967D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
EP3131566B1 (en) * 2014-04-15 2022-10-05 The Regents of the University of California Bi-terminal pegylated integrin-binding peptides and methods of use thereof
JP7081832B2 (ja) 2016-06-13 2022-06-07 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア α（Ｖ）β（６）インテグリン結合ペプチドおよびその使用方法

Similar Documents

Publication Publication Date Title
JP2017513859A5 (enExample)
US8637635B2 (en) Peptides that selectively home to heart vasculature and related conjugates and methods
Li et al. Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells
JP2020178689A (ja) 細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物
CN104262460B (zh) 一种靶向人乳腺癌细胞的多肽及其应用
CN104130315B (zh) 一种特异靶向her2蛋白的多肽
JP2015512246A5 (enExample)
JP7081832B2 (ja) α（Ｖ）β（６）インテグリン結合ペプチドおよびその使用方法
JP2017513859A (ja) 両末端ｐｅｇ化インテグリン結合性ペプチドおよびその使用方法
US20230203098A1 (en) Human transferrin receptor binding peptide
CN105085631A (zh) 一种特异靶向her2蛋白的多肽及其应用
CN107556367B (zh) 一种肿瘤免疫治疗预测生物标志物pd-l2靶向多肽及其应用
JP6417347B2 (ja) 心臓血管に対して選択的にホーミングするペプチド、ならびに関連する結合体および方法
US20180360755A1 (en) Target-specific delivery of therapeutic agents
KR101947529B1 (ko) Rhamm 결합 펩타이드
ES2319624T3 (es) Peptidos que se dirigen al conjunto de vasos linfaticos del tumor y procedimientos de utilizacion de los mismos.
Okarvi et al. Preparation and evaluation of the tumor-specific antigen-derived synthetic mucin 1 peptide: A potential candidate for the targeting of breast carcinoma
WO2019044894A1 (ja) コラーゲンへの結合活性を有する環状ペプチド
JP7824885B2 (ja) 表皮水疱症の治療で使用するためのホーミングペプチド誘導デコリン複合体
US11971412B2 (en) Polypeptide-antibody complexes and uses thereof
KR101735891B1 (ko) 신규한 심혈관계 질환의 진단 및 치료용 펩티드
WO2026022392A1 (en) Peptide and conjugates thereof
US20210023233A1 (en) Antibody-peptide complexes and uses thereof